Candriam Equities L Biotechnology, V - Capitalisation/ LU0317020203 /
| NAV13/01/2025 | Var.+14.9900 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 2,057.0000USD | +0.73% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.61 | 5.39 | -8.19 | 12.61 | -2.42 | 3.86 | -12.36 | 8.75 | -2.82 | - |
| 2017 | 5.51 | 6.90 | -0.08 | 1.23 | -3.06 | 9.25 | 2.56 | 6.40 | 0.81 | -6.34 | 0.29 | 1.54 | +26.78% |
| 2018 | 6.88 | -4.67 | -1.88 | -3.09 | 4.69 | 0.99 | 4.63 | 4.22 | -2.00 | -13.93 | 4.22 | -8.45 | -10.11% |
| 2019 | 13.27 | 3.46 | -0.54 | -4.84 | -4.71 | 9.42 | -2.29 | -2.34 | -4.19 | 10.53 | 11.85 | 2.47 | +33.93% |
| 2020 | -5.17 | -1.12 | -4.99 | 12.89 | 9.37 | 1.42 | -2.84 | 0.94 | 0.78 | -2.79 | 9.82 | 3.08 | +21.34% |
| 2021 | 1.90 | -2.51 | -4.18 | 2.81 | -2.18 | 6.45 | -1.37 | 4.00 | -4.15 | 0.25 | -4.29 | 2.37 | -1.59% |
| 2022 | -10.77 | -1.96 | 5.73 | -7.54 | -3.35 | 3.08 | 4.65 | 1.14 | -1.90 | 7.00 | 6.18 | -2.79 | -2.30% |
| 2023 | 3.02 | -5.67 | 0.45 | 2.29 | -1.19 | 1.26 | -0.13 | -0.15 | -4.28 | -6.10 | 5.99 | 13.49 | +7.70% |
| 2024 | 1.35 | 1.37 | 0.07 | -6.11 | 4.14 | 5.42 | 6.46 | 1.64 | -2.30 | -1.62 | 0.44 | -6.94 | +3.02% |
| 2025 | -1.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 15.94% | 18.20% | 17.14% | 20.33% | 22.81% |
| Indice di Sharpe | -1.72 | -1.18 | -0.17 | 0.12 | 0.11 |
| Mese migliore | -1.00% | +6.46% | +6.46% | +13.49% | +13.49% |
| Mese peggiore | -6.94% | -6.94% | -6.94% | -10.77% | -10.77% |
| Perdita massima | -3.18% | -13.24% | -13.24% | -20.44% | -30.61% |
| Outperformance | -1.00% | - | -1.80% | +3.49% | - |
Tutte le quotazioni in USD
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,033.4200 | -2.08% | +7.90% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,346.5801 | +6.16% | +30.45% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,551.6899 | +3.92% | +31.36% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,854.7000 | +0.44% | +20.65% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 233.3100 | +5.90% | +31.03% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 374.8900 | +4.31% | +35.32% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 346.2800 | +6.87% | +34.59% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 196.2400 | -4.08% | +5.56% | |
| Candriam Equities L Biotechnolog... | reinvestment | 147.0800 | -3.06% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,621.1299 | -0.32% | +16.21% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,057.0000 | -0.17% | +16.78% | |
| Candriam Equities L Biotech.N US... | reinvestment | 597.2600 | -1.03% | +15.37% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 194.7300 | -2.44% | +8.33% | |
| Candriam Equities L Biotech.R US... | reinvestment | 268.4500 | +0.21% | +19.77% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 204.1600 | -1.63% | +11.07% | |
| Candriam Equities L Biotechnolog... | reinvestment | 840.3800 | -0.67% | +16.75% | |
| Candriam Equities L Biotechnolog... | paying dividend | 767.3500 | -0.70% | +16.64% |
Prestazione
| YTD | -1.00% | ||
|---|---|---|---|
| 6 mesi | -9.85% | ||
| 1 anno | -0.17% | ||
| 3 anni | +16.78% | ||
| 5 anni | +29.10% | ||
| 10 anni | - | ||
| Dall'inizio | +105.70% | ||
| Anno | |||
| 2024 | +3.02% | ||
| 2023 | +7.70% | ||
| 2022 | -2.30% | ||
| 2021 | -1.59% | ||
| 2020 | +21.34% | ||
| 2019 | +33.93% | ||
| 2018 | -10.11% | ||
| 2017 | +26.78% | ||
